Varex Imaging Corp
For the period ended Jan 3, 2025. Filed Feb 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jan 3, 2025 · Filed Feb 6, 2025
VREX$18.450.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Three Months Ended | ||
|---|---|---|
| (In millions) | January 3, 2025 | December 29, 2023 |
| Cash flows from operating activities: | ||
| Net loss | $(0.1) | $(0.4) |
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||
| Share-based compensation expense | 4.1 | 3.7 |
| Depreciation | 6.2 | 5.1 |
| Amortization of intangible assets | 0.9 | 3.6 |
| Deferred taxes | 0.1 | (0.8) |
| Loss (income) from equity method investments | 1.7 | (0.4) |
| Amortization of deferred loan costs, net of premium | 0.8 | 0.7 |
| Gain on purchase of business | — | (2.1) |
| Inventory write-down | 0.5 | 0.9 |
| Other, net | 1.9 | (0.5) |
| Changes in assets and liabilities: | ||
| Accounts receivable | 19.5 | 25.3 |
| Inventories, net | (15.6) | (13.2) |
| Prepaid expenses and other assets | (2.4) | 2.2 |
| Accounts payable | 6.8 | 9.0 |
| Accrued liabilities and other current and long-term liabilities | (16.4) | (22.0) |
| Deferred revenues | 1.5 | (0.8) |
| Net cash provided by operating activities | 9.5 | 10.3 |
| Cash flows from investing activities: | ||
| Purchases of property, plant, and equipment | (4.2) | (10.4) |
| Proceeds from sales of marketable debt securities | 9.5 | — |
| Proceeds from maturities of marketable debt securities | 10.6 | 14.2 |
| Purchase of marketable debt securities | (21.4) | (24.5) |
| Proceeds from maturities of certificates of deposit | 3.4 | — |
| Acquisitions of businesses, net of cash acquired | — | 0.9 |
| Other, net | (0.9) | (0.1) |
| Net cash used in investing activities | (3.0) | (19.9) |
| Cash flows from financing activities: | ||
| Taxes related to net share settlement of equity awards | (1.2) | (1.0) |
| Proceeds from issuance of senior secured notes | 126.9 | — |
| Repayments of borrowing under credit agreements | (0.7) | (0.4) |
| Other, net | (0.1) | (0.3) |
| Net cash provided by (used in) financing activities | 124.9 | (1.7) |
| Net increase (decrease) in cash and cash equivalents and restricted cash | 131.4 | (11.3) |
| Cash and cash equivalents and restricted cash at beginning of period | 170.4 | 154.0 |
| Cash and cash equivalents and restricted cash at end of period | $301.8 | $142.7 |
| Supplemental cash flow information: | ||
| Cash paid for interest | $13.7 | $13.7 |
| Income taxes paid, net of refunds | 6.2 | 2.7 |
| Supplemental non-cash activities: | ||
| Purchases of property, plant, and equipment financed through accounts payable | $0.7 | $2.5 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.